Inflammatory breast cancer (IBC) can spread easily through the lymphatic and blood vessels, thus forming new cancer in distant organs which can lead to multi-organ failure.
New research published in BioMed Central's open access journal Cell Communication and Signaling
demonstrates how IBC cells use IL-8, secreted as part of the anti-inflammatory response by a specific set of white blood cells (monocytes), to increase fibronectin expression.
Fibronectin is a cell-adhesion molecule which is usually involved in wound healing and cell migration during embryogenesis. Over-expression of this molecule is thought to allow cancer to metastasize. Prof Mona Mohamed from Cairo University used a cytokine antibody array to identify which immune-regulating molecules (cytokines, chemokines, and growth factors) were secreted by monocytes and found that, while monocytes secreted a small amount each of a wide range of molecules, there was up to 10 times more IL-8 and MCP-1.
The cocktail of immune-regulating molecules from the monocytes was able to increase the amount of fibronectin produced in IBC cells and in 3D culture produced branch-like structures typical of fibronectin over-expression. IL-8 on its own also turned up fibronectin expression in IBC cells. Prof Mohamed explained, "Adding IL-8 on its own to IBC cells caused an increase in the signaling proteins PI3K and AKT and it is this pathway which is responsible for fibronectin production."
The monocyte cocktail did not alter expression of another cell adhesion molecule, E-cadherin. Prof Mohamed continued, "From what we already knew about cell adhesion and these results, it seems that IBC cells are held together in clumps by E-cadherin, but fibronectin, and the IL-8 signaling pathway, are involved in branching and invasion necessary for metastasis of IBC."